株式会社PRISM BioLabTSE 206A
株式会社PRISM BioLab · Pharmaceutical · FY ends Sep
Share price at FY-end
—
FY ending Sep 2025
Avg. director pay
¥21.0M
Internal directors
Top 10 shareholders
| # | Shareholder | Shares | Stake | Value | Dividends |
|---|
| 1 |
DBJキャピタル投資事業有限責任組合
|
5,829,000 |
15.83% |
— |
— |
| 2 |
WMグロース3号投資事業有限責任組合
|
3,675,800 |
9.98% |
— |
— |
| 3 |
大和日台バイオベンチャー2号投資事業有限責任組合
|
3,595,400 |
9.76% |
— |
— |
| 4 |
JPLLC CLIENT ASSETS-SK J
|
2,500,000 |
6.79% |
— |
— |
| 5 |
中島 喜一郎
|
1,872,000 |
5.08% |
— |
— |
| 6 |
santec Holdings株式会社
|
1,250,000 |
3.39% |
— |
— |
| 7 |
竹原 大
|
1,170,400 |
3.17% |
— |
— |
| 8 |
大原薬品工業株式会社
|
1,000,000 |
2.71% |
— |
— |
| 9 |
Newton Biocapital I SA, Pricaf privee de droit belge
|
985,000 |
2.67% |
— |
— |
| 10 |
竹田 英樹
|
935,000 |
2.54% |
— |
— |
Officers' holdings and pay
| Name | Title | Shares | Value | Pay |
|---|
| 竹原 大 |
Representative Director |
1,170,400 |
— |
— |
| 朴 煕万 |
Director |
— |
— |
— |
| 古島 ひろみ |
Director |
— |
— |
— |
| 石黒 雄児 |
Full-time Audit & Supervisory Board Member |
— |
— |
— |
| 田島 照久 |
Audit & Supervisory Board Member |
— |
— |
— |
| 河田 喜一郎 |
Audit & Supervisory Board Member |
— |
— |
— |
| 眞谷 俊誠 |
Audit & Supervisory Board Member |
— |
— |
— |
Pay is shown only for officers whose pay of ¥100 million or more is disclosed individually.
Per-share data by fiscal year
| Fiscal year | Price | EPS | P/E | Dividend | Shares issued |
|---|
| FY ending Sep 2025 |
— |
¥-22.82 |
— |
— |
36,810,000 |
| FY ending Sep 2024 |
— |
¥-33.53 |
— |
— |
35,954,800 |
Source: annual securities reports on EDINET. Values are estimates.
Methodology